New Filings & Updated Terms (Week Ending 08.14.20am) (FREE)

NEW FILINGS

Company: FaceBank Group, Inc.
Symbol: FUBO
Description: fuboTV is the leading sports-first, live TV streaming platform, offering subscribers access to tens of thousands of live sporting events annually as well as leading news and entertainment content. fuboTV’s platform allows customers to access content through streaming devices, and on SmartTVs, mobile phones, tablets and computers.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Evercore ISI
Co-Manager(s): BMO Capital, Needham, Oppenheimer, Roth Capital, Wedbush
Filed: 8-11-20
Listed Cash Raise: $100m.
Note: Their common stock is quoted on the OTCQB Venture Market under the symbol ‘FUBO’. On August 7, 2020, the last reported sale price of their common stock was $10.20 per share.

Company: XPeng Inc.
Symbol: XPEV
Description: They are one of China’s leading smart electric vehicle, or Smart EV, companies.
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Credit Suisse, J.P. Morgan, BofA Securities
Filed: 8-7-20
Listed Cash Raise: $100m

TERMS ADDED

Company: Nano-X Imaging Ltd.
Symbol: NNOX
Description: They are focused on applying their proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe.
Shares: 5.88 million
Price Range: $16.00-$18.00
Market Cap: $663m-$746m
Trade Date: Friday, 8/21
Underwriter(s): Cantor, Oppenheimer & Co., Berenberg, CIBC Capital Markets
Terms Added: 8-14-20

Company: Inhibrx, Inc.
Symbol: INBX
Description: They are a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using our protein engineering expertise and proprietary single domain antibody, or sdAb, platform.
Shares: 6 million
Price Range: $16.00-$18.00
Market Cap: $571m-$642m
Trade Date: Wednesday, 8/19
Underwriter(s): Jefferies, Evercore ISI, Credit Suisse
Co-Manager: LifeSci Capital
Terms Added: 8-12-20
Note: Previously Withdrawn in June 2019

Company: Harmony Biosciences Holdings, Inc.
Symbol: HRMY
Description: They are a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
Shares: 4.65 million
Price Range: $20.00-$23.00
Market Cap: $1.3bn-$1.5bn
Trade Date: Wednesday 8/19
Underwriter(s): Goldman Sachs, Jefferies, Piper Sandler
Terms Added: 8-11-20